Kamama, Rosda .

HRN: 21-32-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/08/2022
IV
750mg
Q8
S/P CS

 Indication:  Prophylaxis    Type of Infection:  BloodstreamSkin & Soft TissueIntra-abdominal    Compliance to guidelines: Non-compliant To Guidelines